Viewing Study NCT02446795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:38 PM
Ignite Modification Date: 2026-02-05 @ 12:41 PM
Study NCT ID: NCT02446795
Status: UNKNOWN
Last Update Posted: 2017-01-18
First Post: 2015-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
Sponsor: Consorzio Oncotech
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
None Kidney Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Renal cell carcinoma View
None Isoquercetin View
None kidney cancer View
None sunitinib View
None fatigue View